NEW YORK (GenomeWeb News) – PerkinElmer has licensed photon detection technology developed by the Max Planck Institute for use in a range of molecular imaging applications, the Waltham, Mass.-based company said today.

Under the exclusive agreement with Max Planck Innovation, the Max Planck Institute's technology transfer arm, the company has licensed solid state silicon photomultiplier, or SiPM, technology that it will use in clinical diagnostics, as well as molecular detection and analytical applications, the company said.